Similarly, artificial lipid NPs coated with TRAIL powerfully ameliorated TRAIL cytotoxic activities in chemoresistant hematological cancer cells and NSCLC, possibly mediated by up-regulating caspase-8 and caspase-3 activation (171). The gene discussed is TNFSF10; the disease is non-small cell lung carcinoma.